These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9436180)

  • 21. AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies.
    Webber S; Bartlett CA; Boritzki TJ; Hillard JA; Howland EF; Johnston AL; Kosa M; Margosiak SA; Morse CA; Shetty BV
    Cancer Chemother Pharmacol; 1996; 37(6):509-17. PubMed ID: 8612303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future challenges in the clinical development of thymidylate synthase inhibitor compounds.
    Brandt DS; Chu E
    Oncol Res; 1997; 9(8):403-10. PubMed ID: 9436193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase: structure, inhibition, and strained conformations during catalysis.
    Montfort WR; Weichsel A
    Pharmacol Ther; 1997; 76(1-3):29-43. PubMed ID: 9535167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
    Rutenber EE; Stroud RM
    Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
    Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
    J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of nematode (parasitic T. spiralis and free living C. elegans), compared to mammalian, thymidylate synthases (TS). Molecular docking and molecular dynamics simulations in search for nematode-specific inhibitors of TS.
    Jarmuła A; Wilk P; Maj P; Ludwiczak J; Dowierciał A; Banaszak K; Rypniewski W; Cieśla J; Dąbrowska M; Frączyk T; Bronowska AK; Jakowiecki J; Filipek S; Rode W
    J Mol Graph Model; 2017 Oct; 77():33-50. PubMed ID: 28826032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2'-Deoxyuridine 5'-monophosphate substrate displacement in thymidylate synthase through 6-hydroxy-2H-naphtho[1,8-bc]furan-2-one derivatives.
    Ferrari S; Calò S; Leone R; Luciani R; Costantino L; Sammak S; Di Pisa F; Pozzi C; Mangani S; Costi MP
    J Med Chem; 2013 Nov; 56(22):9356-60. PubMed ID: 24147825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones.
    Webber SE; Bleckman TM; Attard J; Deal JG; Kathardekar V; Welsh KM; Webber S; Janson CA; Matthews DA; Smith WW
    J Med Chem; 1993 Mar; 36(6):733-46. PubMed ID: 8459400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer antifolates: current status and future directions.
    McGuire JJ
    Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition.
    Stout TJ; Stroud RM
    Structure; 1996 Jan; 4(1):67-77. PubMed ID: 8805515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural aspects of the inhibition and catalytic mechanism of thymidylate synthase.
    Hardy LW
    Acta Biochim Pol; 1995; 42(4):367-80. PubMed ID: 8852328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido)benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
    Li XY; Liang JW; Mohamed O K; Zhang TJ; Lu GQ; Meng FH
    Eur J Med Chem; 2018 Jun; 154():267-279. PubMed ID: 29807332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidylate synthase: a target for anticancer drug design.
    Harrap KR; Jackman AL; Newell DR; Taylor GA; Hughes LR; Calvert AH
    Adv Enzyme Regul; 1989; 29():161-79. PubMed ID: 2633608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis.
    Reich SH; Fuhry MA; Nguyen D; Pino MJ; Welsh KM; Webber S; Janson CA; Jordan SR; Matthews DA; Smith WW
    J Med Chem; 1992 Mar; 35(5):847-58. PubMed ID: 1548676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
    Fantz C; Shaw D; Jennings W; Forsthoefel A; Kitchens M; Phan J; Minor W; Lebioda L; Berger FG; Spencer HT
    Mol Pharmacol; 2000 Feb; 57(2):359-66. PubMed ID: 10648646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based discovery and in-parallel optimization of novel competitive inhibitors of thymidylate synthase.
    Tondi D; Slomczynska U; Costi MP; Watterson DM; Ghelli S; Shoichet BK
    Chem Biol; 1999 May; 6(5):319-31. PubMed ID: 10322126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors.
    Panecka-Hofman J; Pöhner I; Spyrakis F; Zeppelin T; Di Pisa F; Dello Iacono L; Bonucci A; Quotadamo A; Venturelli A; Mangani S; Costi MP; Wade RC
    Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3215-3230. PubMed ID: 28939533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.